This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Whether a ballot measure passed or not, it is still critical for patient advocates to continue fighting for improved access in their state. This blog post focuses on the state ballot measure results only. Because of this, at the time of publication of the blog, we still do not know the winners for a number of key federal seats.
In this blog, we’ll break down what the big news means and what could happen next. Rescheduling would ease those research barriers, improving access to data and education around the plant and opening the door to fully explore the medical benefits cannabis could provide. In the wake of this announcement, you may have a few questions.
While some states have embraced the therapeutic potential of cannabis and established robust medical marijuana programs, others lag behind, leaving patients without access to a potentially life-changing treatment. Disparities in access are primarily driven by the differing state regulations and policies surrounding medical marijuana.
All of us at Canna Law Blog were saddened to learn that the estimable Mark Kleiman passed away over the weekend. Kleiman was probably the most influential scholar on cannabis policy. For just a few of his greatest (and most accessible) hits, check out the following: “ We’re Legalizing Weed Wrong ” (Top 10 list for Slate).
Weedmaps refused to change its policy at the time, citing Section 230 of the 1996 Communications Decency Act, which gives platforms like Facebook and YouTube safe harbor from being held liable for the content their users post.
Employers should: Establish fair and transparent testing policies. Can employers enforce a zero-tolerance cannabis policy? Businesses should ensure written policies are consistent with relevant state and federal employment law. Develop clear, compliant drug policies addressing both medicinal and recreational use.
It argues that laws prohibiting medical marijuana patients from purchasing a gun, even if they have never been convicted of a crime, are unconstitutional and bad policy. How is this a sensible policy? Some people blame easy access to semi-automatic weapons. I hope that you will find this article thought provoking.
Tomorrow, a Republican-controlled Senate Banking Committee hearing will examine cannabis businesses’ lack of access to banking services to further consider the SAFE Banking Act. Cannabis businesses operating legally under state and local laws should have the same access to banking and financial services as any other type of business.”
We have spilled a lot of ink on this blog related to the 2018 Farm Bill , which legalized hemp at the federal level. This blog post is going to cover financial institutions and hemp at about 10,000 feet. This means limited access to institutional lending, ongoing compliance reporting and audits, and short leashes overall.
While we have written on these agency policies individually, we thought it would be helpful to recap these opinions under one blog post. Nevertheless, the substantial public interest in accessing CBD in food and dietary supplements has forced the FDA to explore potential regulatory pathways for the lawful marketing of these products.
Right now, there is an ongoing battle between the state and local governments for access to cannabis, which should be the first place that states (and possibly even Congress) look when considering legalization.
I raised my eyebrows at the ODA post because in addition to this blog, our firm publishes a sister blog, the China Law Blog , where we write on international business (especially China) and frequently warn our readers to protect their intellectual property all costs, whether you are at home or abroad.
Readers of this blog may also recall that Senator Wyden similarly penned a hemp-related letter to the Food and Drug Administration, asking that agency to clarify its stance on hemp-derived CBD in consumable products. We have consistently heard from lawful hemp producers about the lack of access to financial products.
In this blog, we’re discussing the past, present, and future of Iowa medical marijuana laws — exploring its history, laws, regulations, patient access, and the evolving role it plays in the state’s healthcare system. For decades, cannabis was strictly prohibited for both medical and recreational use.
In order to contribute concretely in shaping future EU policies, EAMC is currently working with its members on a medicinal cannabis manifesto, which will identify regulatory solutions that could be implemented by European policymakers.
Medical marijuana (MMJ) dispensaries play a crucial role in providing patients with access to the cannabis products they need for managing various health conditions. Always follow the dispensary’s policies and guidelines, and be considerate of others by maintaining a calm and polite demeanor. Always adhere to these guidelines.
The CSE caters to micro cap and emerging companies and it does not have the restrictive policies of the old-guard TSX (and TSXV) which is the primary Canadian exchange (and the eighth largest in the world, by market cap). More access to institutional capital. That exchange takes U.S. law with respect to cannabis. hemp companies?
Moreover, the lawmakers are hoping that regulatory certainty will provide stakeholders access to banking services and open up new economic opportunities for the industry while at the same time protect consumers. The spending reports mandates the FDA to clear a path for the lawful marketing of these products within 120 days.
The aspect of track-and-trace with the biggest potential for disaster isn’t the fact that it’s so complex, but rather the fact that loss of access to the system could be devastating for licensees. While loss of access to the entire METRC system could happen, it’s probably not very likely.
However, because of the general public’s support of passing these laws in the first place, it would be somewhat unlikely for a state to completely reverse its policy regarding recreational marijuana use. it makes sense that you’re concerned you might not always have access to legal cannabis in the future. can lead to a lot of stress.
New Jersey’s medical marijuana program has been a game-changer for many patients, providing legal access to cannabis for those with qualifying conditions. That said, if your marijuana use affects your job performance or violates company policies, you could still face disciplinary action or termination.
As discussed in this earlier blog post , the SAFE Banking Act aims to prohibit federal regulators from punishing banks and other financial institutions that provide banking services to state-legal marijuana businesses, marijuana-related businesses, and their owners and employees.
Moreover, though Denver was the first place to decriminalize, it’s not the only effort underway to expand access to psilocybin. Even though this is the Canna Law Blog, we’ll continue to provide updates on the state of psilocybin law as it evolves. Again, this is the first time a U.S.
The international market is taking form and access to banking services is expanding. First by the European Union, whose Common Agricultural Policy caps THC concentrations at 0.2 And for good reason: the recreational market is expanding. Hemp is legal. CBD and other cannabinoids are fast becoming (if not already) household names.
It has put state legalization campaigns on hold, delayed sales roll-outs, and the problems in Massachusetts could fill this blog post all by themselves. This week, the state’s Office of Marijuana Policy postponed sales indefinitely due to the pandemic. And there is endless news about the (lack of) relief for marijuana businesses.
According to legal analysis blog JD Supra in December 2020, “The federal Americans with Disabilities Act (ADA) and Rehabilitation Act expressly exclude from coverage employees or applicants “who [are] currently engaging in the illegal use of drugs.” Medical Cannabis and Employment. ” What Federal Law Says. 12114(a); 29 U.S.C. §
From their blog… Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative. The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. By Chloe Reichel.
These challenges include discriminatory policies, limited access to resources and markets, and ongoing racial inequality. Despite facing numerous challenges, including systemic racism and limited access to resources, Black farmers demonstrated resilience and ingenuity in their pursuit of success in the hemp industry.
Then, a blog post circulated online, notifying the industry that Spain’s food and safety authority, AECOSAN, had updated its legislation to prohibit the sale and distribution of products containing CBD being sold as food supplements. Irrespective of where the directive came from, policy on CBD has changed. CBD Regulation is Needed.
Volatile Access to Banking. Lack of access to banking in the industry is the current norm, and it ultimately helps keep cannabis in the shadows and out of reach of full legitimacy and transparency. Oppressive Federal Taxation. .
DEA (9th Circuit), a pending petition for review of DEA’s final decision refusing to provide physicians and terminally ill cancer patients access to psilocybin for therapeutic use under federal and state Right to Try laws. Crown Distributing v. First, he served as co-lead counsel in a mandamus action in the D.C.
We’ve been writing a lot on this blog about the regulation and sale of cannabidiol (“CBD”) products at the state and federal levels. The United States is not the only international actor, however, that is concerned with regulating the sale of CBD products, including CBD-infused foods. extracts of Cannabis sativa L.
In February our blog was honoured and graced with a guest post from non other than Michka , one of our heroines and a true icon of the cannabis scene. Judging from the responses on the blog and social media, however, very few of you actually fell for it. October on the blog featured reports on various conferences.
With the votes tallied, it appears that 13 municipalities voted in favor of initiatives to expand cannabis access that were on the ballot. Some of those municipalities voted to allow cannabis businesses for the first time, while others voted to expand legal access from only medical to adult use.
Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). That access would be available under the auspices of having a chronic, untreatable mood disorder.
Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). It allows patients to have access to medicinal cannabis without danger of being criminalized. Context of the Medicinal Cannabis Situation.
Companies need to have privacy policies that explain to customers what information they have, how they obtained it, and what they do with it. While California already required businesses with websites to have privacy policies, CCPA-type privacy policies will be much more broad and will not just apply to information collected through websites.
Even though laws were put into place that legalized MMJ and made it possible for qualifying patients to access the medication, dispensaries and sales had not yet come into play. According to the Marijuana Policy Project, each state has its own tax laws regarding the legal sale of medical marijuana.
If passed the bill will establish the “Task Force on Psilocybin Equity” that will research problems relating to access and equity in Oregon’s emerging psilocybin program. The task force will complete a study and provide policy recommendations that will serve as a basis for substantive policy reforms during the 2023 legislative session.
It is the first standalone cannabis policy reform bill to ever reach a House floor vote. It aims to address the state-legal cannabis industry’s lack of access to banking and other financial services. “It is only going to grow in urgency and magnitude as states continue to roll back cannabis prohibition policies.
Regulatory Framework and Policy Implications The regulatory framework governing the medical marijuana industry has profound implications for businesses, consumers, and society as a whole. Policy decisions related to taxation, zoning, and advertising also impact the industry’s operations and growth trajectory.
“The literature studying medical marijuana laws is constantly trying to understand whether these policies provide additional opportunities for pain management,” Powell said in an email. The post Report: Medical Marijuana Access Reduces Worker’s Comp Claims appeared first on TheJointBlog.
Understanding MMJ regulations on a state-by-state basis is essential for both patients seeking access to MMJ and the businesses and professionals operating within this industry. To fully grasp the legal status of medical marijuana, one must consider both state-specific regulations and federal policies.
Much remains to be done if the progress made is to be secured, but it is clear that changes are taking place in the global debate on drug policy , especially with regard to cannabis. Today, there is an enormous quantity and varied quality of scientific data, and this study is a fundamental tool that optimizes the way we access it.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content